微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 0.45% | -87.32% | 600% | 104/128 | 4.74% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.09% | -103.49% | 18.18% | 101/128 | 3.02% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.11% | -106.01% | -103.48% | 106/128 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 3.16% | -58.42% | -10.99% | 78/128 | 4.98% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 3.55% | -50.56% | 37.6% | 80/128 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 2.58% | -38.28% | 40.98% | 68/128 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.83% | -6.15% | -75.92% | 64/128 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 7.6% | -2.81% | 5.85% | 75/128 | 13.37% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 7.18% | 8.3% | 71.77% | 70/128 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 4.18% | 23.67% | 114.36% | 74/128 | 9.31% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.95% | 1.04% | -75.06% | 70/128 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 7.82% | -4.98% | 17.95% | 91/128 | 17.51% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 6.63% | -55.2% | 96.15% | 82/128 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 3.38% | -28.09% | 75.13% | 98/128 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.93% | -24.02% | -76.55% | 75/128 | 6.23% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 8.23% | -63.55% | -44.39% | 95/128 | 25.89% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 14.8% | 2% | 214.89% | 41/128 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 4.7% | -60.8% | 85.04% | 71/128 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.54% | 2% | -88.75% | 33/128 | 3.4% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 22.58% | 34.56% | 88.32% | 31/128 | 14.36% | 健尔康 | 84.09% | 行业排名> |
| 2019-06-30 | 11.99% | 2% | -28.55% | 14/128 | 6.73% | 祥生医疗 | 28.56% | 行业排名> |
| 2018-12-31 | 16.78% | 21.86% | 21.86% | 45/128 | 12.98% | 心脉医疗 | 31.04% | 行业排名> |
| 2017-12-31 | 13.77% | 137800% | 137800% | 49/128 | 13.82% | 新华医疗 | 13.55% | 行业排名> |
| 2016-12-31 | -0.01% | 2% | 2% | 73/128 | 16.21% | 安旭生物 | 48.71% | 行业排名> |